바이오노트

377740KOSPI의료용품 및 기타 의약 관련제품 제조업

62.8 / 100

Reference Date: 2026-06-10

Financial Score26.5 / 40

News Sentiment21.3 / 25

Momentum5.0 / 20

Disclosure10.0 / 15

AI Analysis: PBR is significantly undervalued vs. peers but ROE is below the industry average. Declined 6.7% over the past month, and news sentiment is neutral.

Company InformationBased on 2025 Annual Report

Business Overview

BIONOTE is a company established in 2003 specializing in animal diagnostic products and bio-content, leveraging its proprietary recombinant antigen and antibody technology to develop and manufacture rapid immunodiagnostic, enzyme-linked immunosorbent assay (ELISA), and related products. Key offerings include the BIONOTE Rapid and Vcheck F brands, used in veterinary clinics and farms, with expansion into human in vitro diagnostic (IVD) raw material supply.

Number of Employees

334people

Average Salary

49.2M KRW

Score Calculation Basis

Detailed Financial Score

PER

—Industry Average 19.194.0Point

PBR

0.31Industry Average 1.307.0Point

Half of industry avg (excellent)

ROE

-5.56Industry Average -4.893.5Point

In line with industry avg

Debt Ratio

2.09Industry Average 6.866.5Point

Half of industry avg (excellent)

Trend 2023~20255.5 / 10 points

Revenue Growth Rate

2.5 / 3

Avg ▲14.6% (2-year basis)

Operating Profit Growth Rate

3.0 / 3

Avg ▲81.4% (2-year basis)

ROE Trend

0.0 / 4

Avg ROE -1.1% (declining, 3yr)

Detailed News Sentiment

2 totalPositive 2Neutral 0Negative 0Average Sentiment Score 85

Positive
바이오노트, 1분기 영업익 63억…전년比 35.16% 증가
바이오노트의 1분기 영업이익이 전년 대비 크게 증가하여 긍정적인 실적을 발표했다.
Positive
바이오노트가 인수한 씨티씨바이오, 수익성 개선에 주가 16%↑[Why ...
바이오노트의 씨티씨바이오 인수로 인해 고마진 제품 판매 증가로 실적 개선이 이루어져 주가가 크게 상승했다.

Detailed Momentum

52-week position1.0Point

Near 52w low (0%, downtrend)

Current 4,650Won52-week high 6,23052-week low 4,650

1-month return2.0Point

1m -6.72% (slight drop)

Volume trend2.0Point

Volume decreasing

Detailed Disclosure

4 totalPositive 0Neutral 4Negative 0

Neutral기업지배구조보고서공시2026-05-29
Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-05-29
Neutral분기보고서 (2026.03)2026-05-14
Neutral연결재무제표기준영업(잠정)실적(공정공시)2026-05-13